-
Marchés
-
Actions
Sustainable finance2025 Euronext ESG Trends ReportLire la suiteA data-driven snapshot of how Euronext-listed companies are advancing their Environmental, Social and Governance (ESG) practices.
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesLire la suiteThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
ETF
The European market place for ETFsEuronext ETF EuropeLire la suiteInvestors benefit from a centralised market place that will not only bring transparency but also better pricing due to the grouping of liquidity.
- Fonds
-
Obligations
European Defence BondsGroupe BPCE lists the first bondLire la suiteFirst financial institution in Europe to issue a bond dedicated to the defence sector
- Produits Structurés
-
Dérivés
Where European Government Bonds Meet the FutureFixed Income derivativesLire la suiteTrade mini bond futures on main European government bonds
-
Marchandises
- Vue d'ensemble
- Vue d'ensemble
- Power Derivatives
- Milling Wheat derivatives
- Corn derivatives
- Spread contracts
- Rapeseed derivatives
- Durum Wheat derivatives
- Salmon derivatives
- Règlement livraison
- Spécifications et dispositions
- Commitments of Traders (CoT) report
- Commodity brokers
Building a sustainable and liquid power derivatives market.Euronext Nord Pool Power FuturesLire la suiteEuronext and Nord Pool, the European power exchange, announced the launch of a dedicated Nordic and Baltic power futures market.
-
Ressources
Designed to help students navigate the complexities of financial marketsEuronext Trading gameLire la suiteJoin the Euronext Trading Game and step into capital markets. Learn from today’s leaders, explore sustainable opportunities, and trade with confidence.
Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 14 Mar 2023 08:00 CET |
PHOTOCURE | Photocure: New data presented at EAU 2023 highlight the effects of blue light cystoscopy in bladder cancer | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 24 Feb 2023 15:57 CET |
PHOTOCURE | NOTIFICATION OF MAJOR HOLDINGS | 20103015 Pharmaceuticals | Major shareholding notifications |
| 24 Feb 2023 08:17 CET |
PHOTOCURE | Photocure ASA – Major shareholding disclosure | 20103015 Pharmaceuticals | Major shareholding notifications |
| 23 Feb 2023 08:00 CET |
PHOTOCURE | Photocure ASA: Results for the fourth quarter of 2022 | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 20 Feb 2023 07:30 CET |
PHOTOCURE | Clinical data presented at ASCO GU demonstrates reduced risk of recurrence in non-muscle invasive bladder cancer with the use of BLC | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 16 Feb 2023 13:02 CET |
PHOTOCURE | Photocure ASA: Invitation to presentation of 4th quarter and preliminary full year 2022 financial results | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 03 Jan 2023 07:30 CET |
PHOTOCURE | New study publication reinforces the clinical benefits of Blue Light Cystoscopy in the ASC setting; supports ongoing initiatives to further improve reimbursement | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 23 Dec 2022 09:23 CET |
PHOTOCURE | Financial calendar | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |